Recent News

• 10.06.2025 - Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
• 10.06.2025 - Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
• 10.03.2025 - Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 10.03.2025 - Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 10.03.2025 - Li Watsek
• 10.03.2025 - Li Watsek
• 09.22.2025 - Paul Jeng, Ph.D.
• 09.22.2025 - Paul Jeng, Ph.D.
• 09.08.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.08.2025 - H.C. Wainwright 27th Annual Global Investment Conference

Recent Filings

• 09.02.2025 - 8-K Current report
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.06.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]